Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds NextPlat Q2 Sales $2.87M Up From $1.96M YoY

NextPlat Q2 Sales $2.87M Up From $1.96M YoY

NextPlat (NASDAQ:NXPL) reported $2.87 million in sales this quarter. This is a 46.78 percent increase over sales of $1.96 million the same period last year.

byBenzinga Newsdesk

August 15, 2022

1 minute read

NextPlat (NASDAQ:NXPL) reported $2.87 million in sales this quarter. This is a 46.78 percent increase over sales of $1.96 million the same period last year.

JP Morgan Maintains Overweight on Silvergate Capital, Lowers Price Target to $90

By Benzinga Newsdesk

July 1, 9:33 AM

JP Morgan analyst Steven Alexopoulos maintains Silvergate Capital (NYSE:SI) with a Overweight and lowers the price target from $200 to $90.

Earnings

Reinsurance Gr: Q1 Earnings Insights

By Benzinga Insights

May 4, 4:45 PM

Reinsurance Gr (NYSE:RGA) reported its Q1 earnings results on Thursday, May 4, 2023 at 04:15 PM. Here’s what…

RGA

CNB Financial Q2 EPS $0.85 Up From $0.76 YoY, Sales $54.40M Up From $38.30M YoY

By Michael Horton

July 19, 4:17 PM

CNB Financial (NASDAQ:CCNE) reported quarterly earnings of $0.85 per share. This is a 11.84 percent increase over earnings of $0.76 per share from the same period last year. The company reported $54.40 million in sales

CCNE

Leqembi Sales To Propel Biogen Stock To New Heights, Says Bullish Analyst

By Nabaparna Bhattacharya

April 17, 2:07 PM

Piper Sandler analyst Christopher J. Raymond upgraded Biogen Inc (NASDAQ:BIIB) to Overweight, raising the price target to $346. The analyst expects the…

BIIB

NextPlat Q2 Sales $2.87M Up From $1.96M YoY

Related Posts

JP Morgan Maintains Overweight on Silvergate Capital, Lowers Price Target to $90

Reinsurance Gr: Q1 Earnings Insights

CNB Financial Q2 EPS $0.85 Up From $0.76 YoY, Sales $54.40M Up From $38.30M YoY

Leqembi Sales To Propel Biogen Stock To New Heights, Says Bullish Analyst